Publications

2017

Cayrol F, Praditsuktavorn P, Fernando TM, Kwiatkowski N, Marullo R, M Calvo-Vidal N, et al. Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. Nat Commun. 2017;8:14747.
Ku SY, Rosario S, Wang Y, Mu P, Seshadri M, Goodrich ZW, et al. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Science. 2017;355(6320):78-83.
Nakahara T, Dweck MR, Narula N, Pisapia D, Narula J, H Strauss W. Coronary Artery Calcification: From Mechanism to Molecular Imaging. JACC Cardiovasc Imaging. 2017;10(5):582-593.
Simon MS, Westblade LF, Dziedziech A, Visone JE, Furman RR, Jenkins SG, et al. Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia. Clin Infect Dis. 2017;65(7):1222-1225.
Jain M, Wu B, Pisapia D, Salvatore S, Mukherjee S, Narula N. A component-by-component characterisation of high-risk atherosclerotic plaques by multiphoton microscopic imaging. J Microsc. 2017;268(1):39-44.
Pisapia DJ, Salvatore S, Pauli C, Hissong E, Eng K, Prandi D, et al. Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models. JCO Precis Oncol. 2017;2017.
Osorio JC, Jones MG, Schatz-Siemers N, Tang SJ. Twist on a classic: vitamin D and hypercalcaemia of malignancy. BMJ Case Rep. 2017;2017.
Lee D, Fontugne J, Gumpeni N, Park K, MacDonald TY, Robinson BD, et al. Molecular alterations in prostate cancer and association with MRI features. Prostate Cancer Prostatic Dis. 2017;20(4):430-435.
Wang H, Barbieri CE, He J, Gao Y, Shi T, Wu C, et al. Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics. J Transl Med. 2017;15(1):175.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700